Ramaprasad Srinivasan

Financial relationships

  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Employment
    Commercial interest: 
    NIH
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Other
    Commercial interest: 
    Calithera Inc
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Other
    Commercial interest: 
    1) Peloton Therapeutics
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Employment
    Commercial interest: 
    NIH
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Other
    Commercial interest: 
    Calithera Inc
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Other
    Commercial interest: 
    1) Peloton Therapeutics
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Employment
    Commercial interest: 
    NIH
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Other
    Commercial interest: 
    Calithera Inc
  • Disclosure:
    Yes, I have had a relevant financial relationship within the past 12 months.
    Attribution: 
    Self
    Type of financial relationship: 
    Other
    Commercial interest: 
    1) Peloton Therapeutics
Return to Webinar: Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer (2020)